https://seekingalpha.com/article/4659101-snap-up-more-shares?source=feed_all_articles
Dec 21, 2023 - Snap Inc. shares doubled in last quarter and have significant upside potential. Snap's goal for 2024 appears achievable. Find out why SNAP stock is a Buy.
0
sa:964307163945724236
0
https://seekingalpha.com/article/4659317-lsb-a-new-feed-engineering-report-could-push-the-price-up?source=feed_all_articles
Dec 22, 2023 - LSB Industries may unveil a new design for their Houston project, fueling potential sales growth. LXU stock is currently undervalued. Read here for more.
0
sa:120565381448848477
0
https://www.fool.com/investing/2023/12/22/up-132-in-2023-is-it-too-late-to-buy-carnival-stoc/?source=iedfolrf0000001
Dec 22, 2023 - Cruise operator Carnival is benefiting as consumers unleash pent-up demand for travel.
0
fool:8896049680621800686
0
https://www.fool.com/investing/2023/12/23/3-magnificent-high-yield-dividend-stocks-buy-2024/?source=iedfolrf0000001
Dec 23, 2023 - These three stocks have income and growth potential for next year and beyond.
0
fool:1574541791705470705
0
https://www.fool.com/investing/2023/12/24/this-promising-ai-stock-is-up-over-100-in-the-last/?source=iedfolrf0000001
Dec 24, 2023 - Is this the best platform for addressing a $2.4 trillion market?
0
fool:4654443665940047565
0
https://seekingalpha.com/news/4049959-intels-future-may-be-turning-around-one-firm-thinks-it-eventually-splits-up?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Dec 24, 2023 - Intel (INTC) has staked much of its future on the success of its foundry business, but if it splits up, the sum of the parts could be a boon for investors. Read for more.
0
sa:2960164595348652198
0
https://www.fool.com/investing/2023/12/26/why-intel-stock-is-up-big-today/?source=iedfolrf0000001
Dec 26, 2023 - Intel is on track to get another massive round of government support -- this time from outside the U.S.
0
fool:1338059028009388420
0
https://www.fool.com/investing/2023/12/27/carvana-and-carrols-were-2-of-the-biggest-winners/?source=iedfolrf0000001
Dec 27, 2023 - These stocks might be set up for a big run, but what about the underlying businesses?
0
fool:-552459336681753420
0
https://www.rttnews.com/story.aspx?Id=3413807
Dec 28, 2023 - NeuroBo Pharmaceuticals, Inc. (NRBO), a clinical-stage biotechnology company, Thursday said it has submitted Investigational New Drug or IND application to FDA, regarding Phase 1 clinical trial of DA-1726 for the treatment of obesity.
0
rttnews:4190081869345922728
0